Integrative medicine (East Asian herbal medicine combined with conventional medicine) for psoriasis: A protocol for systematic review and meta-analysis.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
20 Jan 2023
20 Jan 2023
Historique:
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
31
1
2023
Statut:
ppublish
Résumé
Psoriasis is a chronic, inflammatory, autoimmune skin disease. The aim of this review is to systematically evaluate the efficacy and safety of integrative medicine (East Asian herbal medicine combined with conventional medicine) used to treat inflammatory skin lesions of psoriasis. A comprehensive literature search will be conducted in 3 English databases (PubMed, Cochrane Library, and Embase), 4 Korean databases (Korean Studies Information Service System, Research Information Service System, Oriental Medicine Advanced Searching Integrated System, and Korea Citation Index), 2 Chinese databases (Chinese National Knowledge Infrastructure Database and Wanfang data), and 1 Japanese database (Citation Information by National Institute of Informatics) for randomized controlled trials from their inception until July 29, 2021. Statistical analysis will be performed using R version 4.1.2 and the R studio program using the default settings of the "meta" and "metafor" packages. The primary outcome will be an improvement in the psoriasis area severity index. All outcomes will be analyzed using a random-effects model to produce more statistically conservative results. If heterogeneity is detected in the study, the cause will be identified through sensitivity, meta-regression, and subgroup analyses. Methodological quality will be assessed independently using the revised tool for the risk of bias in randomized trials, version 2.0. The overall quality of evidence will be evaluated according to the Grading of Recommendations Assessment, Development, and Evaluation pro framework. This study will review all available trials on the same subject and arrive at a more statistically robust conclusion based on a sufficient sample size of participants and additional analysis using data mining techniques will be performed on intervention prescription information in clinical studies collected according to rigorous criteria. We believe that this study will provide useful knowledge on managing inflammatory skin lesions of psoriasis vulgaris using integrative medicine using East Asian herbal medicine.
Sections du résumé
BACKGROUND
BACKGROUND
Psoriasis is a chronic, inflammatory, autoimmune skin disease. The aim of this review is to systematically evaluate the efficacy and safety of integrative medicine (East Asian herbal medicine combined with conventional medicine) used to treat inflammatory skin lesions of psoriasis.
METHODS
METHODS
A comprehensive literature search will be conducted in 3 English databases (PubMed, Cochrane Library, and Embase), 4 Korean databases (Korean Studies Information Service System, Research Information Service System, Oriental Medicine Advanced Searching Integrated System, and Korea Citation Index), 2 Chinese databases (Chinese National Knowledge Infrastructure Database and Wanfang data), and 1 Japanese database (Citation Information by National Institute of Informatics) for randomized controlled trials from their inception until July 29, 2021. Statistical analysis will be performed using R version 4.1.2 and the R studio program using the default settings of the "meta" and "metafor" packages. The primary outcome will be an improvement in the psoriasis area severity index. All outcomes will be analyzed using a random-effects model to produce more statistically conservative results. If heterogeneity is detected in the study, the cause will be identified through sensitivity, meta-regression, and subgroup analyses. Methodological quality will be assessed independently using the revised tool for the risk of bias in randomized trials, version 2.0. The overall quality of evidence will be evaluated according to the Grading of Recommendations Assessment, Development, and Evaluation pro framework.
RESULTS
RESULTS
This study will review all available trials on the same subject and arrive at a more statistically robust conclusion based on a sufficient sample size of participants and additional analysis using data mining techniques will be performed on intervention prescription information in clinical studies collected according to rigorous criteria.
CONCLUSION
CONCLUSIONS
We believe that this study will provide useful knowledge on managing inflammatory skin lesions of psoriasis vulgaris using integrative medicine using East Asian herbal medicine.
Identifiants
pubmed: 36701719
doi: 10.1097/MD.0000000000032360
pii: 00005792-202301200-00023
pmc: PMC9857380
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e32360Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors confirm that there are no known conflicts of interest regarding the publication of this publication. In addition, there is no significant financial support affecting the outcome of this study.
Références
Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet Lond Engl. 2021;397:1301–15.
Parisi R, Symmons DPM, Griffiths CEM, et al. Identification and management of psoriasis and associated comorbidity (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.
Egeberg A, Andersen YMF, Thyssen JP. Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort. BMJ Open. 2019;9:e028116.
Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945–60.
Strober B, Greenberg JD, Karki C, et al. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the corrona psoriasis registry. BMJ Open. 2019;9:e027535.
Mattei PL, Corey KC, Kimball AB. Psoriasis area severity index (PASI) and the dermatology life quality index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol JEADV. 2014;28:333–7.
Singh S, Taylor C, Kornmehl H, et al. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77:425–440.e2.
Ortiz NEG, Nijhawan RI, Weinberg JM. Acitretin. Dermatol Ther. 2013;26:390–9.
Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502–16.
Dabholkar N, Rapalli VK, Singhvi G. Potential herbal constituents for psoriasis treatment as protective and effective therapy. Phytother Res. 2021;35:2429–44.
Hussain Z, Thu HE, Shuid AN, et al. Phytotherapeutic potential of natural herbal medicines for the treatment of mild-to-severe atopic dermatitis: a review of human clinical studies. Biomed Pharmacother Biomedecine Pharmacother. 2017;93:596–608.
Yin CS, Ko SG. Introduction to the history and current status of evidence-based korean medicine: a unique integrated system of allopathic and holistic medicine. Evid Based Compl Altern Med ECAM. 2014;2014:740515.
Shim JM, Kim J. Cross-national differences in the holistic use of traditional East Asian medicine in East Asia. Health Promot Int. 2018;33:536–44.
Shim JM, Lee YS. The association between the use of biomedical services and the holistic use of traditional East Asian medicine: a national survey of outpatients in South Korea. BMJ Open. 2017;7:e018414.
Shim JM. The relationship between the use of complementary and alternative medicine and the use of biomedical services: evidence From East Asian medical systems. Asia Pac J Public Health. 2016;28:51–60.
Guan J, Yuan S, Wu H, et al. Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0173276.
Kim HU, Ryu JY, Lee JO, et al. A systems approach to traditional oriental medicine. Nat Biotechnol. 2015;33:264–8.
Cha WS, Oh JH, Park HJ, et al. Historical difference between traditional Korean medicine and traditional Chinese medicine. Neurol Res. 2007;29(Suppl 1):5S5–9.
Weng SW, Chen BC, Wang YC, et al. Traditional Chinese medicine use among patients with psoriasis in Taiwan: a nationwide population-based study. Evid Based Compl Altern Med ECAM. 2016;2016:3164105.
Su Y, Qin W, Wu L, et al. A review of Chinese medicine for the treatment of psoriasis: principles, methods and analysis. Chin Med. 2021;16:138.
Park M, Hunter J, Kwon S. Evaluating integrative medicine acute stroke inpatient care in South Korea. Health Policy Amst Neth. 2018;122:373–9.
Alschuler L, Chiasson AM, Horwitz R, et al. Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease. Expl N Y N. 2022;18:140–8.
Kim D, Shin JS, Moon YJ, et al. Long-term follow-up of spinal stenosis inpatients treated with integrative Korean medicine treatment. J Clin Med. 2020;10:E74.
Yu HH, Hsieh CJ. Integrative therapy combining Chinese Herbal Medicines with conventional treatment reduces the risk of cardiovascular disease among patients with systemic lupus erythematosus: a retrospective population-based cohort study. Front Pharmacol. 2021;12:737105.
Parvizi MM, Salami MH, Moini Jazani A, et al. Complementary and integrative remedies in the treatment of chronic pruritus: a review of clinical trials. J Cosmet Dermatol. 2022;21:5360–9.
Melby MK, Yoshino T, Tonob D, et al. Differences in demographics and complementary and alternative medicine use between patients attending integrative kampo versus biomedical clinics in Japan. Complement Ther Med. 2019;46:202–9.
Motoo Y, Yukawa K, Hisamura K, et al. Physician perspectives on traditional, complementary, and integrative medicine and the national evidence-based Japanese integrative medicine information website: a mixed-method study. Integr Med Res. 2021;10:100454.
Heo I, Hwang MS, Hwang EH, et al. Electroacupuncture as a complement to usual care for patients with non-acute low back pain after back surgery: a pilot randomised controlled trial. BMJ Open. 2018;8:e018464.
Herman PM, Poindexter BL, Witt CM, et al. Are complementary therapies and integrative care cost-effective?. A systematic review of economic evaluations. BMJ Open. 2012;2:e001046.
Liu Y, May BH, Zhang AL, et al. Integrative herbal medicine for chemotherapy-induced peripheral neuropathy and hand-foot syndrome in colorectal cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2019;18:1534735418817833.
Chen L, Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ. 2017;357:j1284.
Ang L, Song E, Lee MS. Randomized controlled trials of traditional, complementary, and integrative medicine-based interventions for coronavirus disease 2019 (COVID-19): a bibliometric analysis and review of study designs. Integr Med Res. 2021;10:100777.
Fang J, Chen L, Ma R, et al. Comprehensive rehabilitation with integrative medicine for subacute stroke: a multicenter randomized controlled trial. Sci Rep. 2016;6:25850.
Wang C, Lin KYH, Wu MY, et al. Adjunctive Chinese herbal medicine treatment is associated with an improved survival rate in patients with cervical cancer in Taiwan: a matched cohort study. Integr Cancer Ther. 2021;20:15347354211061715347354211061752.
Zhang J, Yu Q, Peng L, et al. Benefits and safety of Chinese herbal medicine in treating psoriasis: an overview of systematic reviews. Front Pharmacol. 2021;12:680172.
Zhang CS, Yang L, Zhang AL, et al. Is oral Chinese Herbal Medicine beneficial for psoriasis vulgaris?. A meta-analysis of comparisons with acitretin. J Altern Compl Med N Y N. 2016;22:174–88.
Deng S, May BH, Zhang AL, et al. Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs. Phytother Res PTR. 2014;28:480–97.
Parker S, Zhang CS, Yu JJ, et al. Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: a systematic review. J Dermatol Treat. 2017;28:21–31.
Luo Y, Chen J, Kuai L, et al. Chinese Herbal Medicine for psoriasis: evidence from 11 high-quality randomized controlled trials. Front Pharmacol. 2020;11:599433.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Lortie CJ, Filazzola A. A contrast of meta and metafor packages for meta-analyses in R. Ecol Evol. 2020;10:10916–21.
Rücker G, Schwarzer G. Beyond the forest plot: the drapery plot. Res Synth Met. 2021;12:13–9.
Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991–6.
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
Yang L, Zhang CS, May B, et al. Efficacy of combining oral Chinese herbal medicine and NB-UVB in treating psoriasis vulgaris: a systematic review and meta-analysis. Chin Med. 2015;10:27.
Zhu Y, Yu J, Zhang K, et al. Network pharmacology analysis to explore the pharmacological mechanism of effective Chinese medicines in treating metastatic colorectal cancer using meta-analysis approach. Am J Chin Med. 2021;49:1839–70.
Ren N, Yu L, Qian L, et al. Exploring the pharmacological mechanism of the effective Chinese medicines against gynecological cancer based on meta-analysis combined with network pharmacology analysis. Front Oncol. 2022;12:817772.
Lu PD, Yuan MC, Quan XP, et al. Preclinical studies of licorice in ulcerative colitis: a systematic review with meta-analysis and network pharmacology. J Ethnopharmacol. 2022;296:115444.